Skip to main content
main-content

07-05-2019 | Multiple sclerosis | Video

AAN 2019: Research emphasizes need to use higher efficacy therapies in younger MS patients

Enrique Alvarez discusses their research demonstrating a difference in the efficacy of multiple sclerosis medications by age, and comments on the implications for clinical practice (5:04).

Funding for independent interviews at AAN 2019 was provided by F.Hoffmann-La Roche Ltd, Basel, Switzerland.